Home / Investments / Start-ups worldwide

Active analysis
Start-ups worldwide
Funding, valuations and the dynamics of start-up ecosystems worldwide.
Questions the analysis answers
- How much venture capital was invested, by year and by region?
- Which sectors attract most of the funding?
- How is the number of “unicorn” companies changing?
The assets on the radar in this domain
44 assets scored on the same 14 conditions: 7 with 10+ conditions met, 20 on watch (6–9) and 17 under 6. The scores are those of the frozen snapshot of 29 October 2026 (JSON file with a SHA-256 fingerprint). 10 have a weekly public price in our database.
| Asset | Category | Conditions | Score | Substance / form | Last price | Before the snapshot | Since the snapshot | Price source |
|---|---|---|---|---|---|---|---|---|
| Stripe | Pre-IPO USA | 12/14 | 8.26 | Substance without form | No public price: not listed (private market) | |||
| Databricks | Pre-IPO USA | 11/14 | 7.7 | Substance confirmed | No public price: not listed (private market) | |||
| Canva | Pre-IPO Australia | 11/14 | 7.6 | Substance without form | No public price: not listed (private market) | |||
| ElevenLabs | Start-up with product United Kingdom | 11/14 | 7.18 | Substance without form | No public price: not listed | |||
| Ramp | Pre-IPO USA | 10/14 | 7.28 | Substance confirmed | No public price: not listed (private market) | |||
| Anduril | Pre-IPO USA | 10/14 | 7.26 | Substance confirmed | No public price: not listed (private market) | |||
| Figma (FIG) | Recently listed USA | 10/14 | 6.74 | Substance without form | 21.65 USD 2026-10-30 | -10.2% | from 2026-11-06 | Yahoo Finance · FIG |
| Revolut | Pre-IPO United Kingdom | 9/14 | 7.28 | Substance confirmed | No public price: not listed (private market) | |||
| ByteDance | Pre-IPO China | 9/14 | 7.14 | Substance without form | No public price: not listed (private market) | |||
| Sierra | Start-up with product USA | 9/14 | 6.8 | Substance confirmed | No public price: not listed | |||
| Lovable | Start-up with product Sweden | 9/14 | 6.76 | Substance confirmed | No public price: not listed | |||
| Plaid | Pre-IPO USA | 8/14 | 6.64 | Substance without form | No public price: not listed (private market) | |||
| Mistral AI | Start-up with product France | 8/14 | 6.62 | Substance without form | No public price: not listed | |||
| SpaceX (SPCX) | Recently listed USA | 8/14 | 6.46 | Substance confirmed | 134.7 USD 2026-10-30 | -8.9% | from 2026-11-06 | Yahoo Finance · SPCX |
| Periodic Labs | Pre-product start-up USA | 8/14 | 5.64 | Substance being confirmed | No public price: not listed | |||
| CATL (3750.HK) | Recently listed China | 7/14 | 7.1 | Substance without form | 338.8 HKD 2026-10-30 | -41.0% | from 2026-11-06 | Yahoo Finance · 3750.HK |
| Cognition | Start-up with product USA | 7/14 | 6.68 | Substance confirmed | No public price: not listed | |||
| Replit | Start-up with product USA | 7/14 | 6.56 | Substance confirmed | No public price: not listed | |||
| AMI Labs | Pre-product start-up France | 7/14 | 5.52 | Substance being confirmed | No public price: not listed | |||
| Circle (CRCL) | Recently listed USA | 6/14 | 6.48 | Substance confirmed | 72.54 USD 2026-10-30 | -28.9% | from 2026-11-06 | Yahoo Finance · CRCL |
| Harvey | Start-up with product USA | 6/14 | 6.4 | Substance confirmed | No public price: not listed | |||
| OpenAI | Pre-IPO USA | 6/14 | 6.38 | Substance confirmed | No public price: not listed (private market) | |||
| Glean | Start-up with product USA | 6/14 | 6.36 | Substance without form | No public price: not listed | |||
| Physical Intelligence | Pre-product start-up USA | 6/14 | 5.6 | Form without substance | No public price: not listed | |||
| Ineffable Intelligence | Pre-product start-up United Kingdom | 6/14 | 5.38 | Substance being confirmed | No public price: not listed | |||
| Unconventional AI | Pre-product start-up USA | 6/14 | 5.22 | Substance being confirmed | No public price: not listed | |||
| Project Prometheus | Pre-product start-up USA | 6/14 | 5.12 | Form without substance | No public price: not listed | |||
| Mercor | Start-up with product USA | 5/14 | 6.72 | Substance confirmed | No public price: not listed | |||
| Kraken (Payward) | Pre-IPO USA | 5/14 | 6.26 | Substance without form | No public price: not listed (private market) | |||
| Chime (CHYM) | Recently listed USA | 5/14 | 6.06 | Substance being confirmed | 27.95 USD 2026-10-30 | -17.2% | from 2026-11-06 | Yahoo Finance · CHYM |
| Perplexity | Start-up with product USA | 5/14 | 5.8 | Substance confirmed | No public price: not listed | |||
| Safe Superintelligence (SSI) | Pre-product start-up USA | 5/14 | 5.36 | Form without substance | No public price: not listed | |||
| Cerebras (CBRS) | Recently listed USA | 4/14 | 5.66 | Substance being confirmed | 109.2 USD 2026-10-30 | -48.0% | from 2026-11-06 | Yahoo Finance · CBRS |
| Thinking Machines Lab | Pre-product start-up USA | 4/14 | 5.12 | Form without substance | No public price: not listed | |||
| Merge Labs | Pre-product start-up USA | 4/14 | 4.86 | Substance being confirmed | No public price: not listed | |||
| Discord | Pre-IPO USA | 3/14 | 6.16 | Substance without form | No public price: not listed (private market) | |||
| Shein | Recently listed Singapore | 3/14 | 5.42 | Substance being confirmed | No public price: no public source | |||
| Klarna (KLAR) | Recently listed Sweden | 3/14 | 5.24 | Substance being confirmed | 13.3 USD 2026-10-30 | -7.7% | from 2026-11-06 | Yahoo Finance · KLAR |
| Figure AI | Start-up with product USA | 3/14 | 4.88 | Form without substance | No public price: not listed | |||
| CoreWeave (CRWV) | Recently listed USA | 2/14 | 5.54 | Substance being confirmed | 54.87 USD 2026-10-30 | -38.6% | from 2026-11-06 | Yahoo Finance · CRWV |
| Reflection AI | Pre-product start-up USA | 2/14 | 5.24 | Form without substance | No public price: not listed | |||
| Humans& | Pre-product start-up USA | 2/14 | 4.82 | Form without substance | No public price: not listed | |||
| StubHub (STUB) | Recently listed USA | 1/14 | 4.16 | Substance being confirmed | 5.78 USD 2026-10-30 | -12.4% | from 2026-11-06 | Yahoo Finance · STUB |
| Gemini (GEMI) | Recently listed USA | 1/14 | 3.88 | Substance being confirmed | 2.87 USD 2026-10-30 | -38.7% | from 2026-11-06 | Yahoo Finance · GEMI |
Each asset, condition by condition
Open an asset to see the score on each condition, explained in plain words, and what it means in short.
Stripe · Pre-IPO · 12/14 · Substance without form
From $50B (2023) to $159B without listing.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 9 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 10 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 9 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 9 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 9 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 9 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 7 | Well-distributed supply: few new shares or tokens ready to flood the market. |
| C8 | Organic community | 8 | Organic community: people came for the product. |
| C9 | Obvious problem | 9 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 6 | Fair price, with no clear discount. |
| C11 | Balanced media | 8 | Balanced attention: neither ignored nor in euphoria. |
| C12 | Healthy price and volume | 8 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 4 | Too many have already bet on it: little room for new buyers. |
| C14 | Low risks | 9 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
Databricks · Pre-IPO · 11/14 · Substance confirmed
Delays listing from strength — the deliberate-delay pattern.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 9 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 9 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 7 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 9 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 9 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 9 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 7 | Organic community: people came for the product. |
| C9 | Obvious problem | 8 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 5 | Fair price, with no clear discount. |
| C11 | Balanced media | 7 | Balanced attention: neither ignored nor in euphoria. |
| C12 | Healthy price and volume | 8 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 4 | Too many have already bet on it: little room for new buyers. |
| C14 | Low risks | 8 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
Canva · Pre-IPO · 11/14 · Substance without form
Profitable; reasonable valuation (~13x revenue).
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 9 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 8 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 8 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 7 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 8 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 8 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 9 | Organic community: people came for the product. |
| C9 | Obvious problem | 8 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 7 | Good entry price: cheap versus rivals, its peak or what it produces. |
| C11 | Balanced media | 7 | Balanced attention: neither ignored nor in euphoria. |
| C12 | Healthy price and volume | 6 | Stable price, no clear signals. |
| C13 | Few on the same bet | 6 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 8 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
ElevenLabs · Start-up with product · 11/14 · Substance without form
Category leader; widely used in media and AI agents.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 8 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 7 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 7 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 7 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 8 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 8 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 7 | Organic community: people came for the product. |
| C9 | Obvious problem | 8 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 5 | Fair price, with no clear discount. |
| C11 | Balanced media | 7 | Balanced attention: neither ignored nor in euphoria. |
| C12 | Healthy price and volume | 8 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 5 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 8 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
Ramp · Pre-IPO · 10/14 · Substance confirmed
Valuation $32B → $44B in 2026.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 8 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 8 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 8 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 8 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 8 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 8 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 6 | A real community, mixed with speculators. |
| C9 | Obvious problem | 7 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 4 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 7 | Balanced attention: neither ignored nor in euphoria. |
| C12 | Healthy price and volume | 9 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 5 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 8 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
Anduril · Pre-IPO · 10/14 · Substance confirmed
Real government contracts; valuation doubled in 2026.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 8 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 9 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 7 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 9 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 8 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 8 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 7 | Organic community: people came for the product. |
| C9 | Obvious problem | 8 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 4 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 6 | Moderate press attention. |
| C12 | Healthy price and volume | 9 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 4 | Too many have already bet on it: little room for new buyers. |
| C14 | Low risks | 7 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
Figma (FIG) · Recently listed · 10/14 · Substance without form
Day-one close $115.50 → -80% since. Strong balance sheet; losses come from stock-based pay.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 7 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 7 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 7 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 8 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 8 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 8 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 8 | Organic community: people came for the product. |
| C9 | Obvious problem | 8 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 6 | Fair price, with no clear discount. |
| C11 | Balanced media | 5 | Moderate press attention. |
| C12 | Healthy price and volume | 3 | The price is falling or erratic, without support. |
| C13 | Few on the same bet | 7 | Few on the same bet: still room for new buyers. |
| C14 | Low risks | 7 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
Revolut · Pre-IPO · 9/14 · Substance confirmed
68M customers; fifth profitable year.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 9 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 8 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 8 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 8 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 8 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 7 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 8 | Organic community: people came for the product. |
| C9 | Obvious problem | 8 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 5 | Fair price, with no clear discount. |
| C11 | Balanced media | 6 | Moderate press attention. |
| C12 | Healthy price and volume | 9 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 4 | Too many have already bet on it: little room for new buyers. |
| C14 | Low risks | 6 | A few risks to watch, nothing serious. |
ByteDance · Pre-IPO · 9/14 · Substance without form
Cheap relative to revenue, but high geopolitical and governance risk (TikTok US).
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 10 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 6 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 9 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 9 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 8 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 7 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 4 | Many shares or tokens may soon hit the market and dilute holders. |
| C8 | Organic community | 8 | Organic community: people came for the product. |
| C9 | Obvious problem | 7 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 8 | Good entry price: cheap versus rivals, its peak or what it produces. |
| C11 | Balanced media | 4 | The press is euphoric: historically, euphoria often marked the top. |
| C12 | Healthy price and volume | 8 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 5 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 4 | High risks: lawsuits, scandals, regulation or geopolitics. |
Sierra · Start-up with product · 9/14 · Substance confirmed
Founded by Bret Taylor (ex-Salesforce, OpenAI chair).
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 7 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 7 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 7 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 7 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 7 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 9 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 4 | The community came mostly for quick gains. |
| C9 | Obvious problem | 7 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 4 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 6 | Moderate press attention. |
| C12 | Healthy price and volume | 8 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 6 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 8 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
Lovable · Start-up with product · 9/14 · Substance confirmed
Reached $100M ARR in 8 months; high churn risk in the category.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 8 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 6 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 7 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 7 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 6 | Customers are real, but part of the activity is artificially boosted. |
| C6 | Credible team | 7 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 8 | Organic community: people came for the product. |
| C9 | Obvious problem | 8 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 4 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 7 | Balanced attention: neither ignored nor in euphoria. |
| C12 | Healthy price and volume | 8 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 4 | Too many have already bet on it: little room for new buyers. |
| C14 | Low risks | 7 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
Plaid · Pre-IPO · 8/14 · Substance without form
Below its 2021 valuation ($13.4B) — a post-capitulation candidate.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 7 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 6 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 7 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 7 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 8 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 7 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 6 | A real community, mixed with speculators. |
| C9 | Obvious problem | 8 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 7 | Good entry price: cheap versus rivals, its peak or what it produces. |
| C11 | Balanced media | 6 | Moderate press attention. |
| C12 | Healthy price and volume | 4 | The price is falling or erratic, without support. |
| C13 | Few on the same bet | 6 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 7 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
Mistral AI · Start-up with product · 8/14 · Substance without form
Europe's champion; EU digital-sovereignty advantage.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 6 | Has users or revenue, but demand is not fully proven yet. |
| C2 | Launch from strength | 7 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 6 | Reasonable funding, with some risk of large sales. |
| C4 | Attracts skilled people | 8 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 6 | Customers are real, but part of the activity is artificially boosted. |
| C6 | Credible team | 8 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 7 | Organic community: people came for the product. |
| C9 | Obvious problem | 7 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 5 | Fair price, with no clear discount. |
| C11 | Balanced media | 7 | Balanced attention: neither ignored nor in euphoria. |
| C12 | Healthy price and volume | 7 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 6 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 7 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
SpaceX (SPCX) · Recently listed · 8/14 · Substance confirmed
Peak $2.66T on 16 Jun, low $108 in July, recovered. Most crowded trade; valued at ~100x revenue.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 9 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 7 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 7 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 9 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 8 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 7 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 4 | Many shares or tokens may soon hit the market and dilute holders. |
| C8 | Organic community | 9 | Organic community: people came for the product. |
| C9 | Obvious problem | 8 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 2 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 4 | The press is euphoric: historically, euphoria often marked the top. |
| C12 | Healthy price and volume | 5 | Stable price, no clear signals. |
| C13 | Few on the same bet | 2 | Too many have already bet on it: little room for new buyers. |
| C14 | Low risks | 6 | A few risks to watch, nothing serious. |
Periodic Labs · Pre-product start-up · 8/14 · Substance being confirmed
Pre-product; own physical lab.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 2 | No users or revenue yet to prove demand; it is mostly a promise. |
| C2 | Launch from strength | 7 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 7 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 8 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 2 | Activity looks bought with rewards or subsidies, not organic. |
| C6 | Credible team | 8 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 5 | A real community, mixed with speculators. |
| C9 | Obvious problem | 8 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 4 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 7 | Balanced attention: neither ignored nor in euphoria. |
| C12 | Healthy price and volume | 6 | Stable price, no clear signals. |
| C13 | Few on the same bet | 7 | Few on the same bet: still room for new buyers. |
| C14 | Low risks | 7 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
CATL (3750.HK) · Recently listed · 7/14 · Substance without form
Peak HK$794.5 (Jun 2026) → -57% in ~4 months; -10% in one day on tax changes. Geopolitical risk.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 9 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 7 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 8 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 8 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 8 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 8 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 6 | A real community, mixed with speculators. |
| C9 | Obvious problem | 9 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 6 | Fair price, with no clear discount. |
| C11 | Balanced media | 5 | Moderate press attention. |
| C12 | Healthy price and volume | 4 | The price is falling or erratic, without support. |
| C13 | Few on the same bet | 6 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 6 | A few risks to watch, nothing serious. |
Cognition · Start-up with product · 7/14 · Substance confirmed
Series D $1B (May 2026). Competes directly with the large labs.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 8 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 6 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 6 | Reasonable funding, with some risk of large sales. |
| C4 | Attracts skilled people | 8 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 7 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 8 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 5 | A real community, mixed with speculators. |
| C9 | Obvious problem | 8 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 3 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 6 | Moderate press attention. |
| C12 | Healthy price and volume | 8 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 4 | Too many have already bet on it: little room for new buyers. |
| C14 | Low risks | 7 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
Replit · Start-up with product · 7/14 · Substance confirmed
In the Forbes AI 50 (2026).
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 7 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 6 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 6 | Reasonable funding, with some risk of large sales. |
| C4 | Attracts skilled people | 8 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 6 | Customers are real, but part of the activity is artificially boosted. |
| C6 | Credible team | 7 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 8 | Organic community: people came for the product. |
| C9 | Obvious problem | 7 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 5 | Fair price, with no clear discount. |
| C11 | Balanced media | 6 | Moderate press attention. |
| C12 | Healthy price and volume | 7 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 5 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 7 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
AMI Labs · Pre-product start-up · 7/14 · Substance being confirmed
Pre-product.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 2 | No users or revenue yet to prove demand; it is mostly a promise. |
| C2 | Launch from strength | 7 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 7 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 8 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 1 | Activity looks bought with rewards or subsidies, not organic. |
| C6 | Credible team | 9 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 6 | A real community, mixed with speculators. |
| C9 | Obvious problem | 7 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 3 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 7 | Balanced attention: neither ignored nor in euphoria. |
| C12 | Healthy price and volume | 6 | Stable price, no clear signals. |
| C13 | Few on the same bet | 6 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 7 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
Circle (CRCL) · Recently listed · 6/14 · Substance confirmed
52-week high $140. Revenue tied to interest rates: falls when rates fall.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 8 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 6 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 7 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 6 | Attracts talent and partners at a normal pace. |
| C5 | Real customers | 7 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 7 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 6 | A real community, mixed with speculators. |
| C9 | Obvious problem | 8 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 5 | Fair price, with no clear discount. |
| C11 | Balanced media | 5 | Moderate press attention. |
| C12 | Healthy price and volume | 5 | Stable price, no clear signals. |
| C13 | Few on the same bet | 5 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 7 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
Harvey · Start-up with product · 6/14 · Substance confirmed
Over $1B raised; clients are large law firms.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 7 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 6 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 6 | Reasonable funding, with some risk of large sales. |
| C4 | Attracts skilled people | 6 | Attracts talent and partners at a normal pace. |
| C5 | Real customers | 7 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 7 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 5 | A real community, mixed with speculators. |
| C9 | Obvious problem | 8 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 4 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 6 | Moderate press attention. |
| C12 | Healthy price and volume | 8 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 5 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 7 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
OpenAI · Pre-IPO · 6/14 · Substance confirmed
Massive cash burn and huge compute commitments; complex legal structure.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 10 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 6 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 3 | Large investors can sell a lot quickly, which can weigh on the price. |
| C4 | Attracts skilled people | 9 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 8 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 6 | Credible team, but without a long track record. |
| C7 | Well-distributed supply | 3 | Many shares or tokens may soon hit the market and dilute holders. |
| C8 | Organic community | 9 | Organic community: people came for the product. |
| C9 | Obvious problem | 9 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 3 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 5 | Moderate press attention. |
| C12 | Healthy price and volume | 7 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 2 | Too many have already bet on it: little room for new buyers. |
| C14 | Low risks | 5 | A few risks to watch, nothing serious. |
Glean · Start-up with product · 6/14 · Substance without form
Stable valuation; category under attack from Microsoft/Google.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 7 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 7 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 6 | Reasonable funding, with some risk of large sales. |
| C4 | Attracts skilled people | 6 | Attracts talent and partners at a normal pace. |
| C5 | Real customers | 7 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 7 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 4 | The community came mostly for quick gains. |
| C9 | Obvious problem | 7 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 6 | Fair price, with no clear discount. |
| C11 | Balanced media | 6 | Moderate press attention. |
| C12 | Healthy price and volume | 5 | Stable price, no clear signals. |
| C13 | Few on the same bet | 6 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 7 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
Physical Intelligence · Pre-product start-up · 6/14 · Form without substance
Pre-product (research models).
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 3 | No users or revenue yet to prove demand; it is mostly a promise. |
| C2 | Launch from strength | 7 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 6 | Reasonable funding, with some risk of large sales. |
| C4 | Attracts skilled people | 8 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 2 | Activity looks bought with rewards or subsidies, not organic. |
| C6 | Credible team | 8 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 6 | A real community, mixed with speculators. |
| C9 | Obvious problem | 8 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 3 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 6 | Moderate press attention. |
| C12 | Healthy price and volume | 7 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 5 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 7 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
Ineffable Intelligence · Pre-product start-up · 6/14 · Substance being confirmed
Pre-product.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 2 | No users or revenue yet to prove demand; it is mostly a promise. |
| C2 | Launch from strength | 7 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 7 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 8 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 1 | Activity looks bought with rewards or subsidies, not organic. |
| C6 | Credible team | 9 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 4 | The community came mostly for quick gains. |
| C9 | Obvious problem | 6 | The problem is real, but not very pressing. |
| C10 | Good entry price | 3 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 6 | Moderate press attention. |
| C12 | Healthy price and volume | 6 | Stable price, no clear signals. |
| C13 | Few on the same bet | 7 | Few on the same bet: still room for new buyers. |
| C14 | Low risks | 7 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
Unconventional AI · Pre-product start-up · 6/14 · Substance being confirmed
Pre-product.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 2 | No users or revenue yet to prove demand; it is mostly a promise. |
| C2 | Launch from strength | 6 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 7 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 7 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 1 | Activity looks bought with rewards or subsidies, not organic. |
| C6 | Credible team | 8 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 4 | The community came mostly for quick gains. |
| C9 | Obvious problem | 7 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 3 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 6 | Moderate press attention. |
| C12 | Healthy price and volume | 6 | Stable price, no clear signals. |
| C13 | Few on the same bet | 7 | Few on the same bet: still room for new buyers. |
| C14 | Low risks | 7 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
Project Prometheus · Pre-product start-up · 6/14 · Form without substance
No product, no revenue, no announced customers.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 2 | No users or revenue yet to prove demand; it is mostly a promise. |
| C2 | Launch from strength | 6 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 9 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 8 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 1 | Activity looks bought with rewards or subsidies, not organic. |
| C6 | Credible team | 8 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 4 | The community came mostly for quick gains. |
| C9 | Obvious problem | 7 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 1 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 5 | Moderate press attention. |
| C12 | Healthy price and volume | 7 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 4 | Too many have already bet on it: little room for new buyers. |
| C14 | Low risks | 7 | Low risks: no lawsuits, scandals or major geopolitical exposure. |
Mercor · Start-up with product · 5/14 · Substance confirmed
Depends on the budgets of the large AI labs.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 9 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 6 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 8 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 6 | Attracts talent and partners at a normal pace. |
| C5 | Real customers | 6 | Customers are real, but part of the activity is artificially boosted. |
| C6 | Credible team | 7 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 4 | The community came mostly for quick gains. |
| C9 | Obvious problem | 7 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 4 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 6 | Moderate press attention. |
| C12 | Healthy price and volume | 9 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 6 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 6 | A few risks to watch, nothing serious. |
Kraken (Payward) · Pre-IPO · 5/14 · Substance without form
Volatile valuations ($20B → $13.3B → $21B).
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 7 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 5 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 7 | Healthy funding: no investors able to flood the market. |
| C4 | Attracts skilled people | 6 | Attracts talent and partners at a normal pace. |
| C5 | Real customers | 7 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 6 | Credible team, but without a long track record. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 7 | Organic community: people came for the product. |
| C9 | Obvious problem | 7 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 6 | Fair price, with no clear discount. |
| C11 | Balanced media | 6 | Moderate press attention. |
| C12 | Healthy price and volume | 5 | Stable price, no clear signals. |
| C13 | Few on the same bet | 6 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 6 | A few risks to watch, nothing serious. |
Chime (CHYM) · Recently listed · 5/14 · Substance being confirmed
52-week range $15.9-35.6. Roughly at its IPO price after 16 months.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 7 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 5 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 6 | Reasonable funding, with some risk of large sales. |
| C4 | Attracts skilled people | 5 | Attracts talent and partners at a normal pace. |
| C5 | Real customers | 7 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 6 | Credible team, but without a long track record. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 6 | A real community, mixed with speculators. |
| C9 | Obvious problem | 7 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 7 | Good entry price: cheap versus rivals, its peak or what it produces. |
| C11 | Balanced media | 5 | Moderate press attention. |
| C12 | Healthy price and volume | 5 | Stable price, no clear signals. |
| C13 | Few on the same bet | 7 | Few on the same bet: still room for new buyers. |
| C14 | Low risks | 6 | A few risks to watch, nothing serious. |
Perplexity · Start-up with product · 5/14 · Substance confirmed
Copyright lawsuits; competes with Google/OpenAI.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 7 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 5 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 5 | Reasonable funding, with some risk of large sales. |
| C4 | Attracts skilled people | 7 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 6 | Customers are real, but part of the activity is artificially boosted. |
| C6 | Credible team | 7 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 7 | Organic community: people came for the product. |
| C9 | Obvious problem | 7 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 3 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 4 | The press is euphoric: historically, euphoria often marked the top. |
| C12 | Healthy price and volume | 6 | Stable price, no clear signals. |
| C13 | Few on the same bet | 4 | Too many have already bet on it: little room for new buyers. |
| C14 | Low risks | 5 | A few risks to watch, nothing serious. |
Safe Superintelligence (SSI) · Pre-product start-up · 5/14 · Form without substance
No product. Co-founder Daniel Gross left (2025).
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 2 | No users or revenue yet to prove demand; it is mostly a promise. |
| C2 | Launch from strength | 9 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 6 | Reasonable funding, with some risk of large sales. |
| C4 | Attracts skilled people | 9 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 1 | Activity looks bought with rewards or subsidies, not organic. |
| C6 | Credible team | 9 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 5 | A real community, mixed with speculators. |
| C9 | Obvious problem | 6 | The problem is real, but not very pressing. |
| C10 | Good entry price | 2 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 7 | Balanced attention: neither ignored nor in euphoria. |
| C12 | Healthy price and volume | 7 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 4 | Too many have already bet on it: little room for new buyers. |
| C14 | Low risks | 6 | A few risks to watch, nothing serious. |
Cerebras (CBRS) · Recently listed · 4/14 · Substance being confirmed
52-week high $386. TD Cowen cut its target below the IPO price (Oct). Few large customers.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 7 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 4 | Rushed to market or listing, usually when enthusiasm peaked. |
| C3 | Healthy funding | 5 | Reasonable funding, with some risk of large sales. |
| C4 | Attracts skilled people | 7 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 4 | Activity looks bought with rewards or subsidies, not organic. |
| C6 | Credible team | 7 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 5 | A real community, mixed with speculators. |
| C9 | Obvious problem | 7 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 5 | Fair price, with no clear discount. |
| C11 | Balanced media | 5 | Moderate press attention. |
| C12 | Healthy price and volume | 3 | The price is falling or erratic, without support. |
| C13 | Few on the same bet | 6 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 6 | A few risks to watch, nothing serious. |
Thinking Machines Lab · Pre-product start-up · 4/14 · Form without substance
Early product (Tinker API). Co-founder departures.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 3 | No users or revenue yet to prove demand; it is mostly a promise. |
| C2 | Launch from strength | 7 | Did not rush: launched (or delays launching) from strength, not out of need for money. |
| C3 | Healthy funding | 6 | Reasonable funding, with some risk of large sales. |
| C4 | Attracts skilled people | 7 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 3 | Activity looks bought with rewards or subsidies, not organic. |
| C6 | Credible team | 8 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 6 | A real community, mixed with speculators. |
| C9 | Obvious problem | 6 | The problem is real, but not very pressing. |
| C10 | Good entry price | 2 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 6 | Moderate press attention. |
| C12 | Healthy price and volume | 7 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 3 | Too many have already bet on it: little room for new buyers. |
| C14 | Low risks | 5 | A few risks to watch, nothing serious. |
Merge Labs · Pre-product start-up · 4/14 · Substance being confirmed
Pre-product; potential conflict of interest with OpenAI.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 1 | No users or revenue yet to prove demand; it is mostly a promise. |
| C2 | Launch from strength | 6 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 6 | Reasonable funding, with some risk of large sales. |
| C4 | Attracts skilled people | 7 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 1 | Activity looks bought with rewards or subsidies, not organic. |
| C6 | Credible team | 7 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 5 | A real community, mixed with speculators. |
| C9 | Obvious problem | 7 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 4 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 6 | Moderate press attention. |
| C12 | Healthy price and volume | 6 | Stable price, no clear signals. |
| C13 | Few on the same bet | 7 | Few on the same bet: still room for new buyers. |
| C14 | Low risks | 5 | A few risks to watch, nothing serious. |
Discord · Pre-IPO · 3/14 · Substance without form
Valuation flat since 2021.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 7 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 5 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 6 | Reasonable funding, with some risk of large sales. |
| C4 | Attracts skilled people | 6 | Attracts talent and partners at a normal pace. |
| C5 | Real customers | 7 | Customers come naturally and pay, not only for rewards. |
| C6 | Credible team | 6 | Credible team, but without a long track record. |
| C7 | Well-distributed supply | 6 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 9 | Organic community: people came for the product. |
| C9 | Obvious problem | 6 | The problem is real, but not very pressing. |
| C10 | Good entry price | 6 | Fair price, with no clear discount. |
| C11 | Balanced media | 5 | Moderate press attention. |
| C12 | Healthy price and volume | 5 | Stable price, no clear signals. |
| C13 | Few on the same bet | 6 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 6 | A few risks to watch, nothing serious. |
Shein · Recently listed · 3/14 · Substance being confirmed
2022 valuation: $100B. Failed listing attempts in the US and London; labour and tariff controversies.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 8 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 3 | Rushed to market or listing, usually when enthusiasm peaked. |
| C3 | Healthy funding | 6 | Reasonable funding, with some risk of large sales. |
| C4 | Attracts skilled people | 5 | Attracts talent and partners at a normal pace. |
| C5 | Real customers | 6 | Customers are real, but part of the activity is artificially boosted. |
| C6 | Credible team | 5 | Credible team, but without a long track record. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 6 | A real community, mixed with speculators. |
| C9 | Obvious problem | 6 | The problem is real, but not very pressing. |
| C10 | Good entry price | 7 | Good entry price: cheap versus rivals, its peak or what it produces. |
| C11 | Balanced media | 3 | The press is euphoric: historically, euphoria often marked the top. |
| C12 | Healthy price and volume | 3 | The price is falling or erratic, without support. |
| C13 | Few on the same bet | 7 | Few on the same bet: still room for new buyers. |
| C14 | Low risks | 3 | High risks: lawsuits, scandals, regulation or geopolitics. |
Klarna (KLAR) · Recently listed · 3/14 · Substance being confirmed
52-week high $47.5. Credit risk; 2021 valuation: $45.6B.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 6 | Has users or revenue, but demand is not fully proven yet. |
| C2 | Launch from strength | 4 | Rushed to market or listing, usually when enthusiasm peaked. |
| C3 | Healthy funding | 4 | Large investors can sell a lot quickly, which can weigh on the price. |
| C4 | Attracts skilled people | 5 | Attracts talent and partners at a normal pace. |
| C5 | Real customers | 6 | Customers are real, but part of the activity is artificially boosted. |
| C6 | Credible team | 5 | Credible team, but without a long track record. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 7 | Organic community: people came for the product. |
| C9 | Obvious problem | 6 | The problem is real, but not very pressing. |
| C10 | Good entry price | 7 | Good entry price: cheap versus rivals, its peak or what it produces. |
| C11 | Balanced media | 4 | The press is euphoric: historically, euphoria often marked the top. |
| C12 | Healthy price and volume | 2 | The price is falling or erratic, without support. |
| C13 | Few on the same bet | 7 | Few on the same bet: still room for new buyers. |
| C14 | Low risks | 5 | A few risks to watch, nothing serious. |
Figure AI · Start-up with product · 3/14 · Form without substance
Deployments still limited; valuation far above revenue.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 4 | No users or revenue yet to prove demand; it is mostly a promise. |
| C2 | Launch from strength | 5 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 5 | Reasonable funding, with some risk of large sales. |
| C4 | Attracts skilled people | 7 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 3 | Activity looks bought with rewards or subsidies, not organic. |
| C6 | Credible team | 6 | Credible team, but without a long track record. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 6 | A real community, mixed with speculators. |
| C9 | Obvious problem | 7 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 2 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 3 | The press is euphoric: historically, euphoria often marked the top. |
| C12 | Healthy price and volume | 7 | Healthy price behaviour: stable or rising, backed by volume. |
| C13 | Few on the same bet | 4 | Too many have already bet on it: little room for new buyers. |
| C14 | Low risks | 5 | A few risks to watch, nothing serious. |
CoreWeave (CRWV) · Recently listed · 2/14 · Substance being confirmed
-59% from 52-week high ($141.8). Very high debt; concentrated on a few large customers.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 8 | Genuinely used: real users or revenue, not just promises. |
| C2 | Launch from strength | 4 | Rushed to market or listing, usually when enthusiasm peaked. |
| C3 | Healthy funding | 2 | Large investors can sell a lot quickly, which can weigh on the price. |
| C4 | Attracts skilled people | 6 | Attracts talent and partners at a normal pace. |
| C5 | Real customers | 5 | Customers are real, but part of the activity is artificially boosted. |
| C6 | Credible team | 6 | Credible team, but without a long track record. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 4 | The community came mostly for quick gains. |
| C9 | Obvious problem | 7 | Obvious problem: explained in one sentence, and people feel it. |
| C10 | Good entry price | 6 | Fair price, with no clear discount. |
| C11 | Balanced media | 5 | Moderate press attention. |
| C12 | Healthy price and volume | 5 | Stable price, no clear signals. |
| C13 | Few on the same bet | 5 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 5 | A few risks to watch, nothing serious. |
Reflection AI · Pre-product start-up · 2/14 · Form without substance
No major commercial product.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 3 | No users or revenue yet to prove demand; it is mostly a promise. |
| C2 | Launch from strength | 6 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 6 | Reasonable funding, with some risk of large sales. |
| C4 | Attracts skilled people | 7 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 3 | Activity looks bought with rewards or subsidies, not organic. |
| C6 | Credible team | 7 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 6 | A real community, mixed with speculators. |
| C9 | Obvious problem | 6 | The problem is real, but not very pressing. |
| C10 | Good entry price | 4 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 6 | Moderate press attention. |
| C12 | Healthy price and volume | 6 | Stable price, no clear signals. |
| C13 | Few on the same bet | 5 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 6 | A few risks to watch, nothing serious. |
Humans& · Pre-product start-up · 2/14 · Form without substance
Pre-product.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 2 | No users or revenue yet to prove demand; it is mostly a promise. |
| C2 | Launch from strength | 6 | The launch timing says nothing special, good or bad. |
| C3 | Healthy funding | 6 | Reasonable funding, with some risk of large sales. |
| C4 | Attracts skilled people | 7 | Skilled people and partners move toward it: value recognised from the inside. |
| C5 | Real customers | 1 | Activity looks bought with rewards or subsidies, not organic. |
| C6 | Credible team | 7 | Credible team: has delivered and has no scandals. |
| C7 | Well-distributed supply | 5 | Balanced supply, with some unlocks or issuance to watch. |
| C8 | Organic community | 4 | The community came mostly for quick gains. |
| C9 | Obvious problem | 5 | The problem is real, but not very pressing. |
| C10 | Good entry price | 3 | Expensive versus rivals or versus what it produces. |
| C11 | Balanced media | 6 | Moderate press attention. |
| C12 | Healthy price and volume | 6 | Stable price, no clear signals. |
| C13 | Few on the same bet | 6 | Some investors are positioned, but it is not crowded. |
| C14 | Low risks | 6 | A few risks to watch, nothing serious. |
StubHub (STUB) · Recently listed · 1/14 · Substance being confirmed
IPO postponed several times; private-equity exit; debt.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 5 | Has users or revenue, but demand is not fully proven yet. |
| C2 | Launch from strength | 2 | Rushed to market or listing, usually when enthusiasm peaked. |
| C3 | Healthy funding | 2 | Large investors can sell a lot quickly, which can weigh on the price. |
| C4 | Attracts skilled people | 4 | Attracts few skilled people, partners or new developers. |
| C5 | Real customers | 5 | Customers are real, but part of the activity is artificially boosted. |
| C6 | Credible team | 4 | The team has scandals, key departures or broken promises. |
| C7 | Well-distributed supply | 4 | Many shares or tokens may soon hit the market and dilute holders. |
| C8 | Organic community | 6 | A real community, mixed with speculators. |
| C9 | Obvious problem | 5 | The problem is real, but not very pressing. |
| C10 | Good entry price | 6 | Fair price, with no clear discount. |
| C11 | Balanced media | 3 | The press is euphoric: historically, euphoria often marked the top. |
| C12 | Healthy price and volume | 1 | The price is falling or erratic, without support. |
| C13 | Few on the same bet | 8 | Few on the same bet: still room for new buyers. |
| C14 | Low risks | 3 | High risks: lawsuits, scandals, regulation or geopolitics. |
Gemini (GEMI) · Recently listed · 1/14 · Substance being confirmed
-89% vs IPO, near its 52-week low. Founded by the Winklevoss twins.
| # | Condition | Score | In plain words |
|---|---|---|---|
| C1 | Actually used | 3 | No users or revenue yet to prove demand; it is mostly a promise. |
| C2 | Launch from strength | 3 | Rushed to market or listing, usually when enthusiasm peaked. |
| C3 | Healthy funding | 3 | Large investors can sell a lot quickly, which can weigh on the price. |
| C4 | Attracts skilled people | 4 | Attracts few skilled people, partners or new developers. |
| C5 | Real customers | 4 | Activity looks bought with rewards or subsidies, not organic. |
| C6 | Credible team | 4 | The team has scandals, key departures or broken promises. |
| C7 | Well-distributed supply | 4 | Many shares or tokens may soon hit the market and dilute holders. |
| C8 | Organic community | 5 | A real community, mixed with speculators. |
| C9 | Obvious problem | 5 | The problem is real, but not very pressing. |
| C10 | Good entry price | 5 | Fair price, with no clear discount. |
| C11 | Balanced media | 3 | The press is euphoric: historically, euphoria often marked the top. |
| C12 | Healthy price and volume | 1 | The price is falling or erratic, without support. |
| C13 | Few on the same bet | 8 | Few on the same bet: still room for new buyers. |
| C14 | Low risks | 4 | High risks: lawsuits, scandals, regulation or geopolitics. |
Weekly prices (the database)
Every Friday, an automated GitHub routine downloads the closes from public sources and adds them here. Points older than a week are no longer changed, and every update stays in the project’s public history. Last update: 5 November 2026.
Backtest: what happened before the snapshot
Read with care: the scores were given on 29 October 2026, after this period. The chart shows the context in which the scores were given, not the radar’s performance. Real performance is measured only from the snapshot onwards (next section).
Computed automatically: in the two months before the snapshot, 0 of 10 assets with a public price rose. The median change was -23.1%, against -1.8% for S&P 500. The smallest fall: Klarna (KLAR) (-7.7%); the largest fall: Cerebras (CBRS) (-48.0%).
Since the snapshot: the radar’s performance
The first measurement runs automatically on Friday, 6 November 2026, against the close of 30 October 2026. From then on, the table above and this paragraph update weekly, with all assets, including those that fell.
Past performance is not a reliable indicator of future results. Prices before fees and taxes. This is not investment advice.
How we apply the 14 conditions here
The same algorithm as for crypto, companies and commodities: each condition gets a score from 0 to 10 and is met from 7. The weights are identical in every domain; only what we measure in practice changes.
| # | Condition | What we measure | Weight |
|---|---|---|---|
| C1 | Actually used | Real revenue, users or demand, not promises. | 16% |
| C2 | Launch from strength | The best don’t rush: they launch when ready. | 6% |
| C3 | Healthy funding | No investors who can sell heavily right away. | 6% |
| C4 | Attracts skilled people | Talent, partners and builders move toward it. | 8% |
| C5 | Real customers | Natural activity, not bought or subsidised. | 6% |
| C6 | Credible team | A record of finishing things, no scandals. | 8% |
| C7 | Well-distributed supply | Few shares or tokens waiting to flood the market. | 8% |
| C8 | Organic community | People who came for the product, not quick gains. | 4% |
| C9 | Obvious problem | Explainable in one sentence. | 6% |
| C10 | Good entry price | Room to grow versus rivals or versus cost. | 6% |
| C11 | Balanced media | Media euphoria has historically marked the top. | 6% |
| C12 | Healthy price and volume | A steady price while usage grows. | 6% |
| C13 | Few on the same bet | The less crowded, the better. | 6% |
| C14 | Low risks | No lawsuits, scandals or major geopolitical risk. | 8% |
Groundwork: official data
The data are being collected from official sources. We show no figure until it has a verifiable source.
Detailed analyses
Start-ups in Europe
European start-up ecosystems, compared by country.
ActiveStart-ups in North America
The US and Canada: the largest pool of venture capital.
ActiveStart-ups in Asia
China, India, Southeast Asia and other Asian ecosystems.
ActiveStart-ups in Oceania
Australia and New Zealand.
PlannedStart-ups in Latin America
Brazil, Mexico and the rest of the region.
PlannedStart-ups in Africa
Nigeria, Kenya, Egypt and South Africa.
Questions about the reasoning
Do you disagree with a score, or want to know why an asset is where it is? Ask. We answer with the weekly update, with sources, by email and, if you agree, here on the page.
Answered questions
Loading…
Sources
- Radar weekly database (CoinGecko and Yahoo Finance closes) (retrieved on 2026-11-05)